CAR-TCR Europe

Overview

CAR-TCR Summit Europe is an annual conference series focused on CAR-T and TCR cell therapies, held in London, UK. It brings together developers, investors, clinical researchers, and experts to discuss technical advancements in receptor engineering, gene editing, manufacturing, and quality control. The event serves as a forum for collaboration in the European cell therapy sector, with the 9th edition scheduled for February 24-26, 2026.

History

The CAR-TCR Summit Europe was launched around 2018 as part of Hanson Wade's conference portfolio in biotech events. It has grown annually, reaching its 9th edition in 2026, reflecting increasing interest in cell therapies. The series has expanded to cover emerging topics like in vivo CAR-T and next-generation TCR strategies amid Europe's rising role in the field.

Notable Products

• 9th Annual CAR-TCR Summit Europe - Three-day conference in London (Feb 24-26, 2026) on CAR-TCR innovations, manufacturing, and clinical progress.
• CAR-TCR Summit Innovations Track - Sessions on in vivo CAR-T, TCR strategies, and engineering approaches for cell therapies.
• CAR-TCR Summit Manufacturing & QC Track - Discussions on cell therapy production, quality control, and supply chain challenges.

Reputation

The summit is regarded by cell therapy professionals as a key European networking event for updates on technical and clinical developments. Attendees value the mix of deep science sessions and industry insights from leaders. Some note it as commercial-focused compared to purely academic meetings, but it remains a standard fixture for biotech stakeholders.